Unlike GLP-1 agonists, metformin’s effects on OSA appear to be primarily mediated through improvements in insulin sensitivity, enhanced mitochondrial function, and reduced oxidative stress [173]. Here, INS is linked to obstructive sleep apnea syndrome.